摘要 |
<p>This invention relates to therapeutic agents, and in particular to the use of compounds such as EP1 antagonists, for reducing uric acid levels in a warm-blooded animal, such as a human. Provided herein is a method of reducing uric acid in a warm-blooded animal comprising administering to said animal an effective amount of an EP1 antagonists. EP1 antagonists are compounds which are antagonists of E-type prostaglandins.</p> |